ABANZA Received FDA 510(k) Clearance for WasherCap™ Mini Implantable Fixation Device, Advancing Soft Tissue Repair Solutions
On February 26, 2025, ABANZA, a leader in advanced soft tissue repair solutions announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for its innovative WasherCap™ Mini fixation system. This groundbreaking device is engineered for a range of applications, including meniscal root repair and ACL reconstruction.
The WasherCap™ Mini is the first suture and tape fixation device that provides surgeons with a knotless, bidirectionally tension-adjustable solution, ensuring optimal performance across varyin...